These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38158237)

  • 1. New ESMO guidelines for clinical practice in metastatic colorectal cancer - commentary on changes in systemic therapy.
    Kiss I
    Klin Onkol; 2023; 37(6):473-476. PubMed ID: 38158237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer.
    Yoshino T; Cervantes A; Bando H; Martinelli E; Oki E; Xu RH; Mulansari NA; Govind Babu K; Lee MA; Tan CK; Cornelio G; Chong DQ; Chen LT; Tanasanvimon S; Prasongsook N; Yeh KH; Chua C; Sacdalan MD; Sow Jenson WJ; Kim ST; Chacko RT; Syaiful RA; Zhang SZ; Curigliano G; Mishima S; Nakamura Y; Ebi H; Sunakawa Y; Takahashi M; Baba E; Peters S; Ishioka C; Pentheroudakis G
    ESMO Open; 2023 Jun; 8(3):101558. PubMed ID: 37236086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.
    Yoshino T; Arnold D; Taniguchi H; Pentheroudakis G; Yamazaki K; Xu RH; Kim TW; Ismail F; Tan IB; Yeh KH; Grothey A; Zhang S; Ahn JB; Mastura MY; Chong D; Chen LT; Kopetz S; Eguchi-Nakajima T; Ebi H; Ohtsu A; Cervantes A; Muro K; Tabernero J; Minami H; Ciardiello F; Douillard JY
    Ann Oncol; 2018 Jan; 29(1):44-70. PubMed ID: 29155929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic treatment for metastatic colorectal cancer.
    Leowattana W; Leowattana P; Leowattana T
    World J Gastroenterol; 2023 Mar; 29(10):1569-1588. PubMed ID: 36970592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.
    van de Velde CJ; Boelens PG; Borras JM; Coebergh JW; Cervantes A; Blomqvist L; Beets-Tan RG; van den Broek CB; Brown G; Van Cutsem E; Espin E; Haustermans K; Glimelius B; Iversen LH; van Krieken JH; Marijnen CA; Henning G; Gore-Booth J; Meldolesi E; Mroczkowski P; Nagtegaal I; Naredi P; Ortiz H; Påhlman L; Quirke P; Rödel C; Roth A; Rutten H; Schmoll HJ; Smith JJ; Tanis PJ; Taylor C; Wibe A; Wiggers T; Gambacorta MA; Aristei C; Valentini V
    Eur J Cancer; 2014 Jan; 50(1):1.e1-1.e34. PubMed ID: 24183379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Metastatic Colorectal Cancer: ASCO Guideline.
    Morris VK; Kennedy EB; Baxter NN; Benson AB; Cercek A; Cho M; Ciombor KK; Cremolini C; Davis A; Deming DA; Fakih MG; Gholami S; Hong TS; Jaiyesimi I; Klute K; Lieu C; Sanoff H; Strickler JH; White S; Willis JA; Eng C
    J Clin Oncol; 2023 Jan; 41(3):678-700. PubMed ID: 36252154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
    Cervantes A; Adam R; Roselló S; Arnold D; Normanno N; Taïeb J; Seligmann J; De Baere T; Osterlund P; Yoshino T; Martinelli E;
    Ann Oncol; 2023 Jan; 34(1):10-32. PubMed ID: 36307056
    [No Abstract]   [Full Text] [Related]  

  • 8. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
    Van Cutsem E; Cervantes A; Adam R; Sobrero A; Van Krieken JH; Aderka D; Aranda Aguilar E; Bardelli A; Benson A; Bodoky G; Ciardiello F; D'Hoore A; Diaz-Rubio E; Douillard JY; Ducreux M; Falcone A; Grothey A; Gruenberger T; Haustermans K; Heinemann V; Hoff P; Köhne CH; Labianca R; Laurent-Puig P; Ma B; Maughan T; Muro K; Normanno N; Österlund P; Oyen WJ; Papamichael D; Pentheroudakis G; Pfeiffer P; Price TJ; Punt C; Ricke J; Roth A; Salazar R; Scheithauer W; Schmoll HJ; Tabernero J; Taïeb J; Tejpar S; Wasan H; Yoshino T; Zaanan A; Arnold D
    Ann Oncol; 2016 Aug; 27(8):1386-422. PubMed ID: 27380959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European expert panel consensus on the clinical management of BRAF
    Martinelli E; Arnold D; Cervantes A; Stintzing S; Van Cutsem E; Tabernero J; Taieb J; Wasan H; Ciardiello F
    Cancer Treat Rev; 2023 Apr; 115():102541. PubMed ID: 36931147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer.
    van Nassau SC; Bond MJ; Scheerman I; van Breeschoten J; Kessels R; Valkenburg-van Iersel LB; Verheul HM; Buffart TE; Mekenkamp LJ; Lemmens VE; Koopman M; Bol GM;
    JAMA Netw Open; 2021 Sep; 4(9):e2124766. PubMed ID: 34505885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Treatment Patterns in Patients With HER2-Amplified Metastatic Colorectal Cancer: A Clinical-Genomic Database Study.
    Strickler JH; Hsu LI; Wright P; Stecher M; Siadak MF; Palanca-Wessels MC; Yu J; Zhang N; Espenschied CR; Lang K; Bekaii-Saab TS
    J Natl Compr Canc Netw; 2023 Aug; 21(8):805-812.e1. PubMed ID: 37549907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metastatic colorectal cancer-Modern treatment strategies and sequences].
    Ettrich TJ; Schuhbaur JS; Seufferlein T
    Inn Med (Heidelb); 2023 Jun; 64(6):546-559. PubMed ID: 37222756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary tumor location and survival among metastatic colorectal cancer patients treated with systemic chemotherapy and biologic therapies: Retrospective analysis.
    Ramadan M; Alfayea T; Alsofyani A; Alyabsi M; Alhusseini N; Algarni AS
    Cancer Treat Res Commun; 2022; 33():100632. PubMed ID: 36088745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Screening and COnsensus Based on Practices and Evidence (SCOPE) Program Results of a Survey on Daily Practice Patterns for Patients with Metastatic Colorectal Cancer-A Swiss Perspective in the Context of an International Viewpoint.
    Siebenhüner AR; Lo Presti G; Helbling D; Szturz P; Astaras C; Buccella Y; De Dosso S
    Curr Oncol; 2022 Aug; 29(8):5604-5615. PubMed ID: 36005180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated treatment recommendation for third-line treatment in advanced colorectal cancer from the ESMO Metastatic Colorectal Cancer Living Guideline.
    Cervantes A; Martinelli E;
    Ann Oncol; 2024 Feb; 35(2):241-243. PubMed ID: 37951473
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sampling survey report on Chinese physicians' cognition of the guidelines on diagnosis and treatment of colorectal cancer].
    Gao ZY; Li M; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1067-1073. PubMed ID: 33212555
    [No Abstract]   [Full Text] [Related]  

  • 17. Sociodemographic and clinical factors associated with receipt of biomarker testing in patients with metastatic colorectal cancer.
    Markt SC; Booker BD; Bensken W; Schiltz NK; Schumacher FR; Rose J; Cooper G; Selfridge JE; Koroukian SM
    Cancer Med; 2023 Jan; 12(2):1850-1859. PubMed ID: 35837788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).
    Phelip JM; Tougeron D; Léonard D; Benhaim L; Desolneux G; Dupré A; Michel P; Penna C; Tournigand C; Louvet C; Christou N; Chevallier P; Dohan A; Rousseaux B; Bouché O
    Dig Liver Dis; 2019 Oct; 51(10):1357-1363. PubMed ID: 31320305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring biological heterogeneity and implications on novel treatment paradigm in BRAF-mutant metastatic colorectal cancer.
    Rodriquenz MG; Ciardiello D; Latiano TP; Maiorano BA; Martinelli E; Silvestris N; Ciardiello F; Maiello E
    Crit Rev Oncol Hematol; 2022 May; 173():103657. PubMed ID: 35337969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-Related Quality of Life in Patients With Metastatic Colorectal Cancer Undergoing Systemic Therapy With or Without Maximal Tumor Debulking.
    Bakkerus L; Buffart LM; Buffart TE; Meyer YM; Zonderhuis BM; Haasbeek CJA; Versteeg KS; Loosveld OJL; de Groot JWB; Hendriks MP; Verhoef C; Verheul HMW; Gootjes EC
    J Natl Compr Canc Netw; 2023 Oct; 21(10):1059-1066.e5. PubMed ID: 37856212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.